Showing results (201-210 of 405) with videos related to
Sort By:
Pageof 41
Neurology and Therapy|May 31, 2020
Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEMMitzi J Williams, Lilyana Amezcua, Annette Okai, et al.Neurology(R) Neuroimmunology & Neuroinflammation|April 18, 2015
Early CNS neurodegeneration in radiologically isolated syndromeChristina J Azevedo, Eve Overton, Sankalpa Khadka, et al.Neuroimage|April 11, 2020
The neurovascular basis of processing speed differences in humans: A model-systems approach using multiple sclerosisDinesh K Sivakolundu, Kathryn L West, Mark Zuppichini, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|February 4, 2009
High-resolution phased-array MRI of the human brain at 7 tesla: initial experience in multiple sclerosis patientsMeredith Metcalf, Duan Xu, Darin T Okuda, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 19, 2025
Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controlsAndrea Salazar-Camelo, Lauren Vega, Yasser Fadlallah, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|November 6, 2014
Identifying the start of multiple sclerosis injury: a serial DTI studyDaniel Ontaneda, Ken Sakaie, Jian Lin, et al.Multiple Sclerosis and Related Disorders|February 14, 2022
Type of serum collection tube does not impact neurofilament light chain levelsElias S Sotirchos, Kathryn C Fitzgerald, Matthew D Smith, et al.Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
Metabolomic Signatures of Brain Atrophy and Ibudilast Response in Progressive Multiple SclerosisMingjing Chen, Rose Noroozi, Matthew D Smith, et al.The International Journal of Neuroscience|October 2, 2014
Experience with fingolimod in clinical practiceCarrie M Hersh, Claire Hara-Cleaver, Richard A Rudick, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 11, 2022
Perspectives and experiences with COVID-19 vaccines in people with MSJohn R Ciotti, Dana C Perantie, Brandon P Moss, et al.Pageof 41